| Author |
Title |
JournalName |
Year D |
| Click on Column Headers to Re-Sort The Current List |
| De Groat WC, Lalley PM |
Depression by p-methoxyphenylethylamine of sympathetic reflex firing e... |
Brain Res |
1973 |
| Nathanson IA, Greengard P |
Serotonin-sensitive Adenylate Cyclase in Neural Tissue and Its Similar... |
Proc Natl Acad Sci |
1974 |
| Jalfre M, Ruch-Monachon M... |
Methods for Assessing the Interaction of Agents with 5-Hydroxytryptami... |
Advances in Psychoph... |
1974 |
| McMahon D |
Chemical Messengers in Development: A Hypothesis. Differentiation of e... |
Science |
1974 |
| Gintzler AR |
Interactions Among Narcotics, Neurotransmitters, and phosphodiesterase... |
Dissertation Abstr I... |
1975 |
| Closse A, Hauser D |
Dihydroergotamine binding to Rat Brain Membranes |
Life Sci. |
1976 |
| Enna SJ, Bennett JP, Burt... |
Stereospecificity of interaction of neuroleptic drugs with neurotransm... |
Nature |
1976 |
| Lovell RA, Freedman DX |
Stereospecific Receptor Sites for d-Lysergic Acid Diethylamide in Rat ... |
Molec. Pharmacol. |
1976 |
| Stewart RM, Growdon JH, C... |
5-Hydroxytryptophan-Induced Myoclonus: Increased Sensitivity to Seroto... |
Neuropharmacology |
1976 |
| Stewart RM, Growdon JH, C... |
Myoclonus After 5 Hydroxytryptophan In Rats With Lesions Of Indoleamin... |
Neurology |
1976 |
| Rosengarten H, Friedhoff ... |
A review of recent studies of the biosynthesis and excretion of halluc... |
Schizophr Bull |
1976 |
| Greengard P |
Cyclic Nucleotides and Phosphorylated Proteins as Targets for Drug Act... |
Acta Pharm. Suecica |
1977 |
| Pickworth WB, Sharpe LG, ... |
Transcallosally Evoked Potentials And the EEG In The Decerebrate Dog: ... |
Electroencephalogram... |
1977 |
| Spano PF, Govoni S, Hofma... |
Physiological and Pharmacological Influences on Dopaminergic Receptors... |
Advances in Biochemi... |
1977 |
| Vogel WH, Evans BD |
Structure-Activity-Relationship Of Certain Hallucinogenic Substances B... |
Life Sci. |
1977 |
| Drummond AH, Bucher F, Le... |
LSD Labels a Novel Dopamine Receptor in Molluscan Nervous System |
Nature |
1978 |
| Degrell I |
Specificity and interaction of the neurotransmitter on the basis of cl... |
Acta Pharm.Hung. |
1978 |
| Martin WR |
The Nature of Opioid and LSD Receptors: Structural Activity Relationsh... |
QUASAR. Quantitative... |
1978 |
| Otis LS, Pryor GT, Marqui... |
Preclinical Identification Of Hallucinogenic Compounds |
Pharmacology of Hall... |
1978 |
| Smythies JR |
On The Molecular Mechanism Of Action Of Hallucinogens |
The Psychopharmacolo... |
1978 |
| Arnt J, Scheel-Krüger J |
GABAergic and Glycinergic Mechanisms Within the Substantia Nigra: Phar... |
Psychopharmacology |
1979 |
| Greengard P |
Cyclic nucleotides, phosphorylated proteins and the nervous system |
Federation Proc. |
1979 |
| Peroutka SJ, Moskowitz MA... |
Neurotransmitter Receptor Binding in Bovine Cerebral Microvessels |
Science |
1980 |
| Kemali M, Kemali D |
Lysergic acid diethylamide (LSD)-induced reversible structural modific... |
Theoretical Problems... |
1982 |
| Palacios JM |
Quantitative Receptor Autoradiography: Application to the Study of Mul... |
CNS Receptors--From ... |
1983 |
| Schmidt CJ, Sonsalla PK, ... |
Methamphetamine-induced depression of monoamine synthesis in the rat: ... |
J Neurochem |
1985 |
| Steele TD, Nichols DE, Yi... |
Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and... |
Biochem Pharmacol |
1987 |
| Scallet AC, Lipe GW, Ali ... |
Neuropathological evaluation by combined immunohistochemistry and dege... |
Neurotoxicology |
1988 |
| Hiramatsu M, Nabeshima T,... |
The effect of optical isomers of 3,4-methylenedioxymethamphetamine (MD... |
Pharmacol Biochem Be... |
1989 |
| Boja JW, Schechter MD |
Possible serotonergic and dopaminergic mediation of the N-ethyl-3,4-me... |
Eur J Pharmacol |
1991 |
| Stohler R, Rommelspacher ... |
[Beta-carbolines (harman/norharman) are increased in heroin dependent ... |
Ther Umsch |
1993 |
| McNamara MG, Kelly JP, Le... |
Some behavioural and neurochemical aspects of subacute (+/-)3,4-methyl... |
Pharmacol Biochem Be... |
1995 |
| Poblete JC, Azmitia EC |
Activation of glycogen phosphorylase by serotonin and 3,4-methylenedio... |
Brain Res |
1995 |
| Lesch KP, Heils A, Rieder... |
The role of neurotransporters in excitotoxicity, neuronal cell death, ... |
J Mol Med |
1996 |
| White SR, Obradovic T, Im... |
The effects of methylenedioxymethamphetamine (MDMA, 'Ecstasy') on mono... |
Prog Neurobiol |
1996 |
| Bitsch A, Thiel A, Rieckm... |
Acute inflammatory CNS disease after MDMA ('ecstasy') |
Eur Neurol |
1996 |
| White JM, Bochner F, Irvi... |
The agony of 'ecstasy' |
Med J Aust |
1997 |
| Crespi D, Mennini T, Gobb... |
Carrier-dependent and Ca(2+)-dependent 5-HT and dopamine release induc... |
Br J Pharmacol |
1997 |
| Sprague JE, Everman SL, N... |
An integrated hypothesis for the serotonergic axonal loss induced by 3... |
Neurotoxicology |
1998 |
| Lerner AG |
Clonidine treatment for hallucinogen persisting perception disorder |
Am J Psychiatry |
1998 |
| Rothman RB, Partilla JS, ... |
Neurochemical neutralization of methamphetamine with high-affinity non... |
Synapse |
2000 |
| Bankson MB, Cunningham KA |
3,4-Methylenedioxymethamphetamine (MDMA) as a Unique Model of Serotoni... |
Journal of Pharmacol... |
2001 |
| Mayerhofer A, Kovar KA, S... |
Changes in serotonin, dopamine and noradrenaline levels in striatum an... |
Neuroscience Letters |
2001 |
| Parrott AC |
Human psychopharmacology of ecstasy; A review of 15 years of empirical... |
Hum Psychopharm Clin... |
2001 |
| Liechti ME, Vollenweider ... |
Which neuroreceptors mediate the subjective effects of MDMA in humans?... |
Hum Psychopharmacol ... |
2001 |
| Bunzow JR, Sonders MS, Ar... |
Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethyla... |
Mol Pharmacol |
2001 |
| Parrott AC |
Recreational Ecstasy/MDMA, the serotonin syndrome, and serotonergic ne... |
Pharmacol Biochem Be... |
2002 |
| Stuerenburg HJ, Petersen ... |
Plasma concentrations of 5-HT, 5-HIAA, norepinephrine, epinephrine and... |
Neuroendocrinol Lett |
2002 |
| Smith KM, Larive LL, Roma... |
Club drugs: methylenedioxymethamphetamine, flunitrazepam, ketamine hyd... |
Am J Health Syst Pha... |
2002 |
| Won L, Bubula N, Heller A |
Fetal exposure to (+/-)-methylenedioxymethamphetamine in utero enhance... |
Brain Res Dev Brain ... |
2002 |
| Holden C |
Drug find could give ravers the jitters |
Science |
2002 |
| Bogen IL, Haug KH, Myhre ... |
Short- and long-term effects of MDMA ("ecstasy") on synaptosomal and v... |
Neurochem Int |
2003 |
| Iversen L |
Cannabis and the brain |
Brain |
2003 |
| Green AR, Mechan AO, Elli... |
The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymetham... |
Pharmacol Rev |
2003 |
| Herraiz T, Chaparro C |
Human monoamine oxidase enzyme inhibition by coffee and beta-carboline... |
Life Sci |
2006 |
| Meltzer PC, Butler D, Des... |
1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analo... |
J Med Chem |
2006 |
| Burchett SA, Hicks TP |
The mysterious trace amines: protean neuromodulators of synaptic trans... |
Prog Neurobiol |
2006 |
| Parrish JC, Nichols DE |
Serotonin 5-HT(2A) receptor activation induces 2-arachidonoylglycerol ... |
J Neurochem |
2006 |
| Wallach JV |
Endogenous hallucinogens as ligands of the trace amine receptors: A po... |
Med Hypotheses |
2008 |
| Gibbons S |
'Legal Highs' - novel and emerging psychoactive drugs: a chemical over... |
Clin Toxicol (Phila) |
2012 |
| Russo EB, Hohmann AG |
Role of Cannabinoids in Pain Management |
Comprehensive Treatm... |
2013 |
| Litjens RP, Brunt TM |
How toxic is ibogaine? |
Clin Toxicol (Phila) |
2016 |
| Zamberlan F, Sanz C, Vivo... |
The varieties of the psychedelic experience: a preliminary study of th... |
Front. Integr. Neuro... |
2018 |
